361 related articles for article (PubMed ID: 18230726)
1. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.
Thomas M; Boname JM; Field S; Nejentsev S; Salio M; Cerundolo V; Wills M; Lehner PJ
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1656-61. PubMed ID: 18230726
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi's sarcoma-associated herpesvirus.
Thomas M; Wills M; Lehner PJ
Biochem Soc Trans; 2008 Jun; 36(Pt 3):459-63. PubMed ID: 18481981
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus ubiquitin ligases downregulate cell surface expression of l-selectin.
Kajikawa M; Imaizumi N; Machii S; Nakamura T; Harigane N; Kimura M; Miyano K; Ishido S; Kanamoto T
J Gen Virol; 2021 Nov; 102(11):. PubMed ID: 34726593
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein.
Ishido S; Choi JK; Lee BS; Wang C; DeMaria M; Johnson RP; Cohen GB; Jung JU
Immunity; 2000 Sep; 13(3):365-74. PubMed ID: 11021534
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.
Dunn C; Chalupny NJ; Sutherland CL; Dosch S; Sivakumar PV; Johnson DC; Cosman D
J Exp Med; 2003 Jun; 197(11):1427-39. PubMed ID: 12782710
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication.
Brulois K; Toth Z; Wong LY; Feng P; Gao SJ; Ensser A; Jung JU
J Virol; 2014 Aug; 88(16):9335-49. PubMed ID: 24899205
[TBL] [Abstract][Full Text] [Related]
7. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.
Doubrovina ES; Doubrovin MM; Vider E; Sisson RB; O'Reilly RJ; Dupont B; Vyas YM
J Immunol; 2003 Dec; 171(12):6891-9. PubMed ID: 14662896
[TBL] [Abstract][Full Text] [Related]
8. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
[TBL] [Abstract][Full Text] [Related]
9. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.
Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T
J Immunol; 2003 Apr; 170(8):4196-200. PubMed ID: 12682252
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradation.
Rhodes DA; Boyle LH; Boname JM; Lehner PJ; Trowsdale J
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16240-5. PubMed ID: 20805500
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142.
Chalupny NJ; Rein-Weston A; Dosch S; Cosman D
Biochem Biophys Res Commun; 2006 Jul; 346(1):175-81. PubMed ID: 16750166
[TBL] [Abstract][Full Text] [Related]
12. Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells.
Matthews NC; Goodier MR; Robey RC; Bower M; Gotch FM
Eur J Immunol; 2011 Jul; 41(7):1958-68. PubMed ID: 21509779
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family.
Dimasi N; Sawicki MW; Reineck LA; Li Y; Natarajan K; Margulies DH; Mariuzza RA
J Mol Biol; 2002 Jul; 320(3):573-85. PubMed ID: 12096910
[TBL] [Abstract][Full Text] [Related]
14. The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases.
Nathan JA; Lehner PJ
Exp Cell Res; 2009 May; 315(9):1593-600. PubMed ID: 19013150
[TBL] [Abstract][Full Text] [Related]
15. Genetically coupled receptor-ligand pair NKp80-AICL enables autonomous control of human NK cell responses.
Klimosch SN; Bartel Y; Wiemann S; Steinle A
Blood; 2013 Oct; 122(14):2380-9. PubMed ID: 23929856
[TBL] [Abstract][Full Text] [Related]
16. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
Song H; Kim J; Cosman D; Choi I
Cell Immunol; 2006 Jan; 239(1):22-30. PubMed ID: 16630603
[TBL] [Abstract][Full Text] [Related]
17. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR
J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088
[TBL] [Abstract][Full Text] [Related]
18. Attenuated natural killer (NK) cell activation through C-type lectin-like receptor NKp80 is due to an anomalous hemi-immunoreceptor tyrosine-based activation motif (HemITAM) with impaired Syk kinase recruitment capacity.
Rückrich T; Steinle A
J Biol Chem; 2013 Jun; 288(24):17725-33. PubMed ID: 23609447
[TBL] [Abstract][Full Text] [Related]
19. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.
Carbone E; Neri P; Mesuraca M; Fulciniti MT; Otsuki T; Pende D; Groh V; Spies T; Pollio G; Cosman D; Catalano L; Tassone P; Rotoli B; Venuta S
Blood; 2005 Jan; 105(1):251-8. PubMed ID: 15328155
[TBL] [Abstract][Full Text] [Related]
20. Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function.
Roda-Navarro P; Vales-Gomez M; Chisholm SE; Reyburn HT
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11258-63. PubMed ID: 16849432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
